JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lawson, J. W.
Right arrow Articles by Uyeda, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lawson, J. W.
Right arrow Articles by Uyeda, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 262, Issue 7, 3165-3173, Mar, 1987

Effects of insulin and work on fructose 2,6-bisphosphate content and phosphofructokinase activity in perfused rat hearts

JW Lawson and K Uyeda

The effects of insulin and increased cardiac work on glycolytic rate, metabolite content, and fructose 2,6-bisphosphate (Fru-2,6-P2) content were studied in isolated perfused rat hearts. Steady-state rates of glycolysis increased 5-fold with the addition of insulin to the perfusate or by increasing cardiac pressure-volume work and correlated well in most conditions with changes in substrate concentration (Fru-6- P) and with concentration of the activator, Fru-2,6-P2. There was no correlation with changes in other well known regulators including citrate, ATP, AMP, Pi, or cytosolic phosphorylation potential. Using phosphofructokinase purified from hearts perfused under identical conditions, allosteric kinetic experiments were performed using the metabolite and effector concentrations determined from in vivo experiments. Reaction rates for phosphofructokinase calculated in vitro agreed well with the glycolytic rates measured in vivo and correlated with changes in Fru-6-P but not with other effectors. However, higher Fru-2,6-P2 levels were more effective in maintaining phosphofructokinase activity at high ATP and citrate levels. Kinetic experiments did not indicate a covalent modification of phosphofructokinase. These data indicate that control of cardiac phosphofructokinase and glycolysis may be accomplished by changes in the availability of substrate, Fru-6-P, and activator, Fru-2,6-P2, rather than by citrate, adenine nucleotides, or cytosolic phosphorylation potential as previously suggested.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk
Myocardial Substrate Metabolism in the Normal and Failing Heart
Physiol Rev, July 1, 2005; 85(3): 1093 - 1129.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Nascimben, J. S. Ingwall, B. H. Lorell, I. Pinz, V. Schultz, K. Tornheim, and R. Tian
Mechanisms for Increased Glycolysis in the Hypertrophied Rat Heart
Hypertension, November 1, 2004; 44(5): 662 - 667.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Tian, N. Musi, J. D'Agostino, M. F. Hirshman, and L. J. Goodyear
Increased Adenosine Monophosphate-Activated Protein Kinase Activity in Rat Hearts With Pressure-Overload Hypertrophy
Circulation, October 2, 2001; 104(14): 1664 - 1669.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. F. Allard, R. B. Wambolt, S. L. Longnus, M. Grist, C. P. Lydell, H. L. Parsons, B. Rodrigues, J. L. Hall, W. C. Stanley, and G. P. Bondy
Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin
Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E487 - E493.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Depre, J.-L. J. Vanoverschelde, and H. Taegtmeyer
Glucose for the Heart
Circulation, February 2, 1999; 99(4): 578 - 588.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. W. Brownsey, A. N. Boone, and M. F. Allard
Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms
Cardiovasc Res, April 1, 1997; 34(1): 3 - 24.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Lefebvre, M.-C. Mechin, M. P. Louckx, M. H. Rider, and L. Hue
Signaling Pathway Involved in the Activation of Heart 6-Phosphofructo-2-kinase by Insulin
J. Biol. Chem., September 13, 1996; 271(37): 22289 - 22292.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1987 by the American Society for Biochemistry and Molecular Biology.